GB0313915D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0313915D0
GB0313915D0 GBGB0313915.1A GB0313915A GB0313915D0 GB 0313915 D0 GB0313915 D0 GB 0313915D0 GB 0313915 A GB0313915 A GB 0313915A GB 0313915 D0 GB0313915 D0 GB 0313915D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0313915.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GBGB0313915.1A priority Critical patent/GB0313915D0/en
Publication of GB0313915D0 publication Critical patent/GB0313915D0/en
Priority to JP2006515936A priority patent/JP2006527722A/en
Priority to EP04739898A priority patent/EP1656367A1/en
Priority to PCT/EP2004/006427 priority patent/WO2004111036A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
GBGB0313915.1A 2003-06-16 2003-06-16 Compounds Ceased GB0313915D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0313915.1A GB0313915D0 (en) 2003-06-16 2003-06-16 Compounds
JP2006515936A JP2006527722A (en) 2003-06-16 2004-06-14 4- (Heterocycle-fused phenyl) -3- (phenyl or pyrid-2-yl) pyrazole as an inhibitor of the ALK-5 receptor
EP04739898A EP1656367A1 (en) 2003-06-16 2004-06-14 4- (heterocyclyl- fused phenyl)- 3- (phenyl or pyrid -2- yl) pyrazoles as inhibitors of the alk-5- receptor
PCT/EP2004/006427 WO2004111036A1 (en) 2003-06-16 2004-06-14 4- (heterocyclyl- fused phenyl)- 3- (phenyl or pyrid -2- yl) pyrazoles as inhibitors of the alk-5- receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0313915.1A GB0313915D0 (en) 2003-06-16 2003-06-16 Compounds

Publications (1)

Publication Number Publication Date
GB0313915D0 true GB0313915D0 (en) 2003-07-23

Family

ID=27636631

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0313915.1A Ceased GB0313915D0 (en) 2003-06-16 2003-06-16 Compounds

Country Status (4)

Country Link
EP (1) EP1656367A1 (en)
JP (1) JP2006527722A (en)
GB (1) GB0313915D0 (en)
WO (1) WO2004111036A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2004000234A1 (en) * 2003-02-12 2005-04-15 Biogen Idec Inc DERIVATIVE COMPOUNDS 3- (PIRIDIN-2-IL) -4-HETEROARIL-PIRAZOL SUBSTITUTED, ANTAGONISTS OF AIK5 AND / OR AIK4; PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND IN THE TREATMENT OF FIBROTIC DISORDERS AS SCLERODERMIA, LUPUS NEFRITICO, CICATRIZACION DE HERID
TW200639163A (en) * 2005-02-04 2006-11-16 Genentech Inc RAF inhibitor compounds and methods
US20100056505A1 (en) * 2005-11-21 2010-03-04 Biogen Idec Ma Inc. Substituted Pyrazalones
EP1998796A2 (en) * 2006-03-28 2008-12-10 Wyeth a Corporation of the State of Delaware Gdf-9/bmp-15 modulators for the treatment of bone disorders
US7989458B2 (en) * 2006-07-14 2011-08-02 Novartis Ag Pyrimidine derivatives as alk-5 inhibitors
EP1878733A1 (en) * 2006-07-14 2008-01-16 Novartis AG Pyrimidine derivatives as ALK-5 inhibitors
TW201107303A (en) * 2009-05-27 2011-03-01 Sanofi Aventis Process for the production of benzofurans
TWI582083B (en) * 2014-10-07 2017-05-11 美國禮來大藥廠 Aminopyridyloxypyrazole compounds
CN107663206B (en) 2016-07-29 2021-06-18 上海璎黎药业有限公司 Nitrogen-containing aromatic heterocyclic compound, preparation method thereof, pharmaceutical composition and application thereof
AU2019396360A1 (en) 2018-12-11 2021-05-27 Theravance Biopharma R&D Ip, Llc Naphthyridine and quinoline derivatives useful as ALK5 inhibitors
EP4061809A1 (en) * 2019-11-22 2022-09-28 Theravance Biopharma R&D IP, LLC Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors
EP4173675A1 (en) * 2021-10-26 2023-05-03 Perha Pharmaceuticals Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3734180B2 (en) * 1994-12-28 2006-01-11 エーザイ株式会社 New pyrazole derivatives
GB0027987D0 (en) * 2000-11-16 2001-01-03 Smithkline Beecham Plc Compounds
GB0102672D0 (en) * 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
CA2440211A1 (en) * 2001-03-09 2002-09-19 Pfizer Products Inc. Benzimidazole anti-inflammatory compounds
AU2002356301A1 (en) * 2001-12-21 2003-07-15 Cancer Research Technology Ltd. 3,4-diarylpyrazoles and their use in the therapy of cancer
AU2003259475A1 (en) * 2002-09-18 2004-04-08 Pfizer Products Inc. Pyrazole derivatives as transforming growth factor (TGF) inhibitors
CL2004000234A1 (en) * 2003-02-12 2005-04-15 Biogen Idec Inc DERIVATIVE COMPOUNDS 3- (PIRIDIN-2-IL) -4-HETEROARIL-PIRAZOL SUBSTITUTED, ANTAGONISTS OF AIK5 AND / OR AIK4; PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND IN THE TREATMENT OF FIBROTIC DISORDERS AS SCLERODERMIA, LUPUS NEFRITICO, CICATRIZACION DE HERID

Also Published As

Publication number Publication date
WO2004111036A1 (en) 2004-12-23
JP2006527722A (en) 2006-12-07
EP1656367A1 (en) 2006-05-17

Similar Documents

Publication Publication Date Title
GB0309781D0 (en) Compounds
GB0316915D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1658301A4 (en) N-desmethyl-n-substituted-11-deoxyerythromycin compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0302512D0 (en) Compounds
GB0304494D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0307998D0 (en) Compounds
GB0310066D0 (en) Compounds
GB0305721D0 (en) Compounds
GB0310069D0 (en) Compounds
GB0314698D0 (en) Compounds
GB0311688D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)